Gaudium IPO: Related party deals, tax demands at fast-growing IVF chain raise governance questions
Gaudium IVF is set to launch its IPO but governance experts are flagging intra-group financial transactions and tax investigations. A promoter's substantial share sale and high professional fees raise questions, with concerns about promoter revenue streams and compliance.
Gaudium IVF is set to launch its IPO but governance experts are flagging intra-group financial transactions and tax investigations. A promoter's substantial share sale and high professional fees raise questions, with concerns about promoter revenue streams and compliance.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
